Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Sensors (Basel, Switzerland)
|
May 1, 2019
Performance Criteria for the Identification of Inertial Sensor Error Models
Oleg Stepanov, Andrei Motorin
Sensors (Basel, Switzerland)
|
December 31, 2025
Recursive Batch Smoother with Multiple Linearization for One Class of Nonlinear Estimation Problems: Application for Multisensor Navigation Data Fusion
Oleg Stepanov, Alexey Isaev, Elena Dranitsyna, et al.
Pharmaceutics
|
May 27, 2023
Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric Population
Andrew Lim, Pradeep Sharma, Oleg Stepanov, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 22, 2022
A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics
Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
January 25, 2021
Longitudinal FEV<sub>1</sub> and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
Kirill Zhudenkov, Robert Palmér, Alexandra Jauhiainen, et al.
Antimicrobial Agents and Chemotherapy
|
March 27, 2024
Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19
Lindsay E Clegg, Oleg Stepanov, Henning Schmidt, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 4, 2026
Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling
Marija Kekic, Oleg Stepanov, Wenjuan Wang, et al.
Clinical Pharmacology in Drug Development
|
September 5, 2025
Safety and Pharmacokinetics of Long-Acting Monoclonal Antibodies Tixagevimab and Cilgavimab (AZD7442) in a China Phase 2 Study and Evaluation of Asian Race Effect
Jing Zhang, Huixia Zhang, Yajuan Zhang, et al.
Clinical & Translational Immunology
|
June 14, 2024
Serum AZD7442 (tixagevimab-cilgavimab) concentrations and <i>in vitro</i>IC<sub>50</sub> values predict SARS-CoV-2 neutralising antibody titres
Lindsay E Clegg, Oleg Stepanov, Sam Matthews, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 1, 2024
In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection
Christine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Sensors (Basel, Switzerland)
|
May 1, 2019
Performance Criteria for the Identification of Inertial Sensor Error Models
Oleg Stepanov, Andrei Motorin
Sensors (Basel, Switzerland)
|
December 31, 2025
Recursive Batch Smoother with Multiple Linearization for One Class of Nonlinear Estimation Problems: Application for Multisensor Navigation Data Fusion
Oleg Stepanov, Alexey Isaev, Elena Dranitsyna, et al.
Pharmaceutics
|
May 27, 2023
Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric Population
Andrew Lim, Pradeep Sharma, Oleg Stepanov, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 22, 2022
A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics
Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
January 25, 2021
Longitudinal FEV<sub>1</sub> and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
Kirill Zhudenkov, Robert Palmér, Alexandra Jauhiainen, et al.
Antimicrobial Agents and Chemotherapy
|
March 27, 2024
Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19
Lindsay E Clegg, Oleg Stepanov, Henning Schmidt, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 4, 2026
Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling
Marija Kekic, Oleg Stepanov, Wenjuan Wang, et al.
Clinical Pharmacology in Drug Development
|
September 5, 2025
Safety and Pharmacokinetics of Long-Acting Monoclonal Antibodies Tixagevimab and Cilgavimab (AZD7442) in a China Phase 2 Study and Evaluation of Asian Race Effect
Jing Zhang, Huixia Zhang, Yajuan Zhang, et al.
Clinical & Translational Immunology
|
June 14, 2024
Serum AZD7442 (tixagevimab-cilgavimab) concentrations and <i>in vitro</i>IC<sub>50</sub> values predict SARS-CoV-2 neutralising antibody titres
Lindsay E Clegg, Oleg Stepanov, Sam Matthews, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 1, 2024
In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection
Christine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Page
of 2